Almac Group is proud of its global reputation for excellence, delivering expertise right across the drug development lifecycle and offering a tailored solution to each client.
Our client relationships are long term and they are underpinned by one simple commitment:
We will be exceptional, always.
Latest from Almac
February 18th, 2020
Almac Clinical Services’ Just in Time Manufacturing Operations Pass EU Regulatory Inspection
January 08th, 2020
Galen, an Almac company, announces completion of multi-million pound POA Pharma acquisition
October 21st, 2019
Almac Group £35 million Brexit Solution Complete with EU distribution centre attaining successful HPRA inspection
Almac Brexit Resource Hub
Partnering to advance human healthExplore our locations
Almac recognises that you need bespoke solutions to suit your needs. Only we can combine the expertise from our world leading range of specialised drug development services to support you across the full biopharmaceutical product lifecycle, from the preclinical stages through to commercialisation.
Almac Diagnostic Services is our stratified medicine business unit, specialising in biomarker driven clinical trials. Our global laboratories, in the UK and US, offer tailored solutions from discovery to commercialisation: biomarker discovery, assay development & validation, CDx development & commercialisation. Your clinical trial diagnostic partner.
Almac Discovery is a research driven, oncology business unit within Almac dedicated to the discovery and development of novel, innovative approaches to the treatment of cancer. We focus on early stage development and partner programmes with the pharmaceutical industry at the discovery to preclinical stage.
Workshop: Ensuring Supply Chain Flexibility and Viability for Biologics
25 February 2020 West Coast, USAEvent info
26 February 2020 New York CityEvent info
Almac’s STEM Pathway programme
27 February 2020 W5, BelfastEvent info
Molecular Med Tri-Con (MMTC) 2020
02 March 2020 San Francisco, CAEvent info